P2 Capital Partners, LLC
P2 Capital Partners, LLC is a company.
Active
Updated: ·
Financial History
Total Raised
N/A
Valuation
N/A
Leadership Team
Key people at P2 Capital Partners, LLC.
P2 Capital Partners, LLC is a company.
Key people at P2 Capital Partners, LLC.
Key people at P2 Capital Partners, LLC.
P2 Capital Partners, LLC is a New York-based investment firm founded in 2007 that operates as a collaborative “operational activist” hedge fund, applying a private equity-style approach to small-cap public companies.[1][2] The firm's mission centers on achieving capital appreciation by building concentrated portfolios of 12-15 high-quality businesses—typically with market caps between $1-3 billion—through significant ownership stakes and close collaboration with management to drive value via operational initiatives and leveraged buyouts (LBOs).[1][2] Its investment philosophy emphasizes long-term holdings, active engagement as the most influential shareholder, and catalyzing exits like take-privates or sales to private equity firms or strategics, managing around $1.3 billion in discretionary assets as of early 2024 with recent 13F holdings valued at $522 million.[2][3] P2 impacts the startup and public market ecosystem by providing operational expertise to under-optimized small-caps, often unlocking value in sectors like industrials, healthcare, and tech as seen in top holdings such as CBIZ Inc. (24.79% of portfolio), JBT Marel Corp., and Acadia Healthcare.[3]
P2 Capital Partners was established in 2007 by Claus Jorgen Moller in New York City, starting as a hedge fund manager focused on public equities with a private equity twist.[1][2] From its base at 590 Madison Avenue, the firm evolved under key partners like Kareem Hammad, growing to 16 employees while maintaining a lean structure amid competitors like Blackstone and KKR.[1] Its focus sharpened on small-cap publics ripe for operational activism, leveraging LBO capabilities for exits—about 50% of which involve sales to PE or strategics—building a track record of concentrated, multi-year positions that prioritize business quality and value creation over broad diversification.[1][2][3]
P2 Capital rides the wave of small-cap undervaluation in public markets, where operational activism addresses inefficiencies in high-quality firms overlooked by larger investors amid rising interest rates and PE dry powder.[2][3] Timing favors its model as small-caps ($1-3B) face M&A droughts, making LBOs and strategic sales potent catalysts—evident in portfolio shifts toward resilient sectors like ad tech (Integral Ad Science) and healthcare (Acadia).[3] Market forces like sector consolidation and activist pressure boost P2, influencing the ecosystem by professionalizing management in public small-caps, bridging public-to-private transitions, and delivering returns through hands-on value creation in a fragmented mid-market.[1][2]
P2 Capital is poised to capitalize on small-cap rebounds, potentially expanding LBO activity as rates stabilize and PE capital deploys into take-privates of its core holdings like CBIZ or Acadia.[2][3] Trends like AI-driven efficiency in portfolio ops and activist surges will shape its path, with influence growing via larger deals in consolidating sectors. As a nimble operator in a giant's game, P2's private equity lens on publics positions it to thrive, echoing its 2007 roots in delivering outsized returns through collaboration.